New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime insulin to improve glycemic control.

Investing.com -- MannKind Corporation (NASDAQ:MNKD) stock rose 3.5% Monday after the company announced that the U.S. Food and Drug Administration (FDA) approved an update to the prescribing ...

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. AARP’s Medicare experts share tips and updates to help manage ...

Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...

The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.

Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart insulin pens with a glucose sensor made by Abbott.

The system provides personalised, real-time insights and actionable guidance. Credit: Medtronic. Medtronic has received US Food and Drug Administration (FDA) 510(k) clearance for its MiniMed Go Smart ...

MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...

The InPen smart insulin pen, Instinct sensor and MiniMed Go app [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for ...

Background: Circadian syndrome (CircS) extends metabolic syndrome by incorporating sleep and mood components, demonstrating superior predictive value for cardiovascular outcomes. Insulin resistance ...